Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model

Blood

Volumn 113, Issue 9, 2009, Pages 2079-2087

  Kelher, Marguerite R ^a,b   Masuno, Tomhiko ^b,c   Moore, Ernest E ^b,d   Damle, Sagar ^b,d   Meng, Xianzhong ^b   Song, Yong ^b   Liang, Xiayuan ^e   Niedzinski, Jerry ^f   Geier, Steven S ^f   Khan, Samina Y ^a,b   Gamboni Robertson, Fabia ^b   Silliman, Christopher C ^a,b  

^a Bonfils Blood Center   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d DENVER HEALTH MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL COLORADO   (United States)

^f LABS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; ENDOTOXIN; EVANS BLUE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OX18 ANTIBODY; OX27 ANTIBODY; OXIDOREDUCTASE; PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; HISTOLOGY; HUMAN; HUMAN CELL; LUNG; LUNG EDEMA; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT;

EID: 61849133300     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-177857     Document Type: Article

References (87)

1. Eder AF, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007;47:599-607.
2. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18:184-188.
3. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44:1774-1789.
4. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33:721-726.
5. Popovsky MA. Transfusion related acute lung injury. In: Popovsky MA, ed. Transfusion Reactions. Bethesda, MD: AABB Press; 2001:168-184.
6. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105: 2266-2273.
7. Renaudier PC, Vo Mai MP, Azanowsky JM, et al. Epidemiology of transfusion related acute lung injury in Gifit, the Frech Hemovigilance Database. a study of the French Hemovigilance Network [abstract]. Transfusion. 2004;44:23A.
8. Wallis JP, LubenkoA, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion. 2003;43:1053-1059.
9. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116:1615-1623.
10. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573-577.
11. Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. 2006;107:1217-1219.
12. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76:1438-1444.
13. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43:633-640.
14. Yomtovian R, Kline W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet. 1984;1:244-246.
15. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287:1968-1971.
16. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion. 2004;44: 1683-1688.
17. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion. 1990;30: 42-45.
18. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997; 37:719-726.
19. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458-1467.
20. Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood. 2007;109:1752-1755.
21. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release.Am J Physiol Cell Physiol. 2002;283:C1592-C1603.
22. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108: 2455-2462.
23. Technical Manual. Bethesda, MD: American Association of Blood Banks; 2002.
24. Masuno T, Moore EE, Cheng AM, et al. Prehospital hemoglobin-based oxygen carrier resuscitation attenuates postinjury acute lung injury. Surgery. 2005;138:335-341.
25. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med. 1985;26:72-76.
26. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105:322-329.
27. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev. 2006;20:139-159.
28. Song Y, Ao L, Raeburn CD, et al. A low level of TNF-alpha mediates hemorrhage-induced acute lung injury via p55 TNF receptor. Am J Physiol Lung Cell Mol Physiol. 2001;281:L677-L684.
29. Johnson JL, Moore EE, Hiester AA, et al. Disparities in the respiratory burst between human and rat neutrophils. J Leukoc Biol. 1999;65:211-216.
30. Sheridan BC, McIntyre RC, Agrafojo J, et al. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation. Am J Physiol. 1996;271:L820-L828.
31. Raeburn CD, Calkins CM, Zimmerman MA, et al. ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation.Am J Physiol Regul Integr Comp Physiol. 2002;283:R477-R486.
32. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124:684-694.
33. Himi T, Yoshioka I, Kataura A. Production and gene expression of IL-8-like cytokine GRO/ CINC-1 in rat nasal mucosa. Acta Otolaryngol. 1997;117:123-127.
34. Takaishi K, Ohtsuka T, Tsuneyoshi S, et al. Inhibition of the production of rat cytokine-induced neu-trophil chemoattractant (CINC)-1, a member of the interleukin-8 family, by adenovirus-mediated overexpression of IkappaBalpha. J Biochem. 2000;127:511-516.
35. Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996;36:133-139.
36. Arnold R, Konig W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol. 2005;174:7359-7367.
37. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil- endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis. 1998;177:1465-1474.
38. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol. 2004;85:1801-1813.
39. Vilela MC, Mansur DS, Lacerda-Queiroz N, et al. Traffic of leukocytes in the central nervous system is associated with chemokine up-regulation in a severe model of herpes simplex encephalitis: an intravital microscopy study. Neurosci Lett. 2008;445:18-22.
40. Covin RB, Ambruso DR, England KM, et al. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus Med. 2004;14:375-383.
41. Keifer JC, Kingsley CP, Roth MT, Abt AB, Romano PJ. Transfusion-related acute lung injury (TRALI) complicating colectomy for ulcerative colitis. Anesthesiology. 1998;89:1020-1023.
42. Medeiros BC, Kogel KE, Kane MA. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apheresis Sci. 2003;29:25-27.
43. Roffey P, Thangathurai D, Mikhail M, Riad M, Mogos M. TRALI and massive transfusion. Resuscitation. 2003;58:121.
44. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454-462.
45. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004;126:249-258.
46. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med. 2006;34: S124-S131.
47. Standiford TJ, Kunkel SL, Lukacs NW, et al. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol. 1995;155:1515-1524.
48. Chollet-Martin S, Jourdain B, Gibert C, et al. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS.Am J Respir Crit Care Med. 1996;154:594-601.
49. Jorens PG, Van DJ, De BW, et al. Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine. 1992;4:592-597.
50. Rabinovici R, Yeh CG, Hillegass LM, et al. Role of complement in endotoxin/platelet-activating factor-induced lung injury. J Immunol. 1992;149: 1744-1750.
51. Rana R, Vlahakis NE, Daniels CE, et al. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med. 2006;34:1941-1946.
52. Sirithunyanont C, Leowattana W, Sukumalchantra Y, et al. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. J Med Assoc Thai. 2003;86(suppl 1):S87-S95.
53. Cartron J, Tchernia G, Celton JL, et al. Alloimmune neonatal neutropenia. Am J Pediatr Hematol Oncol. 1991;13:21-25.
54. Fadeyi EA, De Los Angeles MM, Wayne AS, et al. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion. 2007;47:545-550.
55. Wallis JP, Haynes S, Stark G, et al. Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion. Lancet. 2002; 360:1073-1074.
56. Fukumoto T, McMaster WR, Williams AF. Mouse monoclonal antibodies against rat major histocompatibility antigens: two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol. 1982;12:237-243.
57. Luo D, Vermijlen D, Kuppen PJ, Wisse E. MHC class I expression protects rat colon carcinoma cells from hepatic natural killer cell-mediated apoptosis and cytolysis, by blocking the perforin/ granzyme pathway. Comp Hepatol. 2002;1:2-10.
58. Metzger R, Mempel T, Joppich I, Till H. Organ-specific distribution of major histocompatibility antigens in rats. Pediatr Surg Int. 2000;16:285-292.
59. Metzger R, Parasta A, Joppich I, Till H. Organ-specific maturation of the major histocompatibility antigens in rats. Pediatr Surg Int. 2002;18:640-647.
60. Smits KM, Kuppen PJ, Eggermont AM, et al. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 onA-NK cells and the absence of major histocompatibility complex class I on target cells. Eur J Immunol. 1994;24:171-175.
61. Howard JC. The major histocompatibility complex of the rat: a partial review. Metabolism. 1983;32: 41-50.
62. Hurt P, Walter L, Sudbrak R, et al. The genomic sequence and comparative analysis of the rat major histocompatibility complex. Genome Res. 2004;14:631-639.
63. Lambracht-Washington D, Moore YF, Wonigeit K, Lindahl KF. Structure and expression of MHC class Ib genes of the central M region in rat and mouse: M4, M5, and M6. Immunogenetics. 2008; 60:131-145.
64. Walter L, Gunther E. Physical mapping and evolution of the centromeric class I gene-containing region of the rat MHC. Immunogenetics. 2000;51: 829-837.
65. Gunther E, Walter L. The major histocompatibility complex of the rat (Rattus norvegicus). Immuno-genetics. 2001;53:520-542.
66. Joly E, Rouillon V. The orthology of HLA-E and H2-Qa1 is hidden by their concerted evolution with other MHC class I molecules. Biol Direct. 2006;1:2-19.
67. Allaerts W, Salomon B, Leenen PJ, et al. A population of interstitial cells in the anterior pituitary with a hematopoietic origin and a rapid turnover: a relationship with folliculo-stellate cells? J Neuroimmunol. 1997;78:184-197.
68. Durlik M, Lukomska B, Ziolkowska H, et al. Microchimerism following allogeneic vascularized bone marrow transplantation; its possible role in induction of posttransplantation tolerance. Ann Transplant. 1998;3:24-26.
69. Matsumoto S, Takei M, Moriyama M, Imanishi H. Enhancement of Ia-like antigen expression by interferon-gamma in polymorphonuclear leukocytes. Chem Pharm Bull (Tokyo). 1987;35:436-439.
70. Matsumoto Y, Fujiwara M. In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis: an immunohistochemical study. J Neuroimmunol. 1986;12:265-277.
71. Matsumoto Y, Fujiwara M.Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J Neuro-immunol. 1987;17:71-82.
72. Matsumoto Y, Kawai K, Fujiwara M. Hemorrhagic autoimmune encephalomyelitis induced by adoptive transfer of activated semiallogeneic spleen cells into irradiated rats. Am J Pathol. 1988;133: 306-315.
73. Olszewski WL, Durlik M, Lukomska B, et al. Donor DNA can be detected in recipient tissues during rejection of allograft. Transpl Int. 2000; 13(suppl 1):S461-S464.
74. Jin F, Tayab ZR, Balthasar JP. Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia. AAPS J. 2005;7: E895-E902.
75. Scherzer H, Ward PA. Lung injury produced by immune complexes of varying composition. J Immunol. 1978;121:947-952.
76. Hébert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289:1941-1949.
77. Plurad D, Belzberg H, Schulman I, et al. Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. Am Surg. 2008;74:117-123.
78. Watkins TR, Rubenfeld GD, Martin TR, et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med. 2008;36:1493-1499.
79. Han I, Saito H, Fukatsu K, et al. Ex vivo fluorescence microscopy provides simple and accurate assessment of neutrophil-endothelial adhesion in the rat lung. Shock. 2001;16:143-147.
80. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest. 1990;85:1135-1143.
81. Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion. 2005;45: 109S-116S.
82. Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol. 1999;66:10-24.
83. Woodman RC, Teoh D, Payne D, Kubes P. Thrombin and leukocyte recruitment in endotoxemia. Am J Physiol Heart Circ Physiol. 2000;279: H1338-H1345.
84. Abraham E. Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc. 2005;2:243-247.
85. O'Brien JM Jr, Abraham E. Human models of endotoxemia and recombinant human activated protein C. Crit Care Med. 2004;32:S202-S208.
86. Middelburg RA, van Stein D, Zupanska B, et al. Inconsistent association between donor gender and clinically defined TRALI [abstract]. J Thromb Haemostas. 2008;6.
87. Boshkov LK, Maloney J, Bieber S, Silliman CC. Two cases of TRALI from the same platelet unit: implications for pathophysiology and the role of PMNs and VEGF. [abstract]. Blood. 2000;96:655a.